Paracentesis is the standard treatment for refractory ascites in patients with cirrhosis, but it cannot prevent the recurrence of ascites. The placement of a transjugular intrahepatic portosystemic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In a retrospective cohort study, ...

A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to transjugular intrahepatic portosystemic shunt, or TIPS, according to a recently ...

The Ascites may be due to cancer like ovarian malignancy. Cirrhosis of liver is the most common cause and the underlying liver disease is to be addressed first. The patient has to be counselled to ...

THE effect of increased intra-abdominal pressure due to ascites upon portal and systemic hemodynamics has not been directly documented although the hemodynamics of ascitic cirrhotic patients have been ...

HERNIA is known to be more frequent among patients with cirrhosis of the liver, especially with ascites, than among those without liver disease. Chapman et al. 1 reported a rate of 10 per cent in 58 ...

Background: A 63-year-old Caucasian woman presented with intermittent, left-sided abdominal discomfort without other symptoms. Physical examination revealed massive splenomegaly and complete blood ...

Rising prevalence of cirrhosis is a major factor boosting the growth of the global malignant ascites market. According to a study published in the World Journal of Gastroenterology in 2011, over 50% ...

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Ascites Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ...